Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea

• Conditions: Obstructive Sleep Apnoea; Hypertension

• Registration Number: NCT01685736
• Lead Sponsor: University of Athens

Brief Summary

Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02
• Status Verified: 2012-09
• Study First Submitted: 2012-09-11
• Study First Submitted QC: 2012-09-11
• Last Update Submitted: 2012-09-11
• Study First Posted: 2012-09-14
• Last Update Posted: 2012-09-14
• Primary Completion: 2013-06
• Study Completion: 2013-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age ≤ 65 years
• Suspected OSA
• Treated or untreated for hypertension

Exclusion Criteria

• History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke)
• History of asthma or chronic obstructive pulmonary disease (FEV1/FVC <70%)
• History of diabetes mellitus, collagen diseases and sarcoidosis
• Serum creatinine >1.6 mg/dl, proteinuria
• Previous treatment with CPAP
• Pregnancy or menstruation during the study
• Treatment with steroids, lithium or any other drugs affecting BP
• Change in antihypertensive treatment(if any) in the last 8 weeks before study entry

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (2)

Hypertension Center, Third Department of Medicine, University of Athens, Greece; 🇬🇷 Athens, Greece

First University Department of Respiratory Medicine, Sotiria Hospital; 🇬🇷 Athens, Greece